Lena Bundschuh

Augsburg, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

A Tumor Volume Segmentation Algorithm Based on Radiomics Features in FDG-PET in Lung Cancer Patients, Validated Using Surgical Specimens.

A Tumor Volume Segmentation Algorithm Based on Radiomics Features in FDG-PET in Lung Cancer Patients, Validated Using Surgical Specimens.

Journal: Diagnostics (Basel, Switzerland)

Published: September 17, 2024

Interobserver Agreement Rates on CXCR4-Directed PET/CT in Patients with Marginal Zone Lymphoma.

Interobserver Agreement Rates on CXCR4-Directed PET/CT in Patients with Marginal Zone Lymphoma.

Journal: Molecular imaging and biology

Published: February 09, 2024

Interobserver Agreement Rates on C-X-C Motif Chemokine Receptor 4-Directed Molecular Imaging and Therapy.

Interobserver Agreement Rates on C-X-C Motif Chemokine Receptor 4-Directed Molecular Imaging and Therapy.

Journal: Clinical nuclear medicine

Published: March 22, 2023

High Interobserver Agreement on PSMA PET/CT Even in the Absence of Clinical Data.

High Interobserver Agreement on PSMA PET/CT Even in the Absence of Clinical Data.

Journal: Clinical nuclear medicine

Published: February 01, 2023

Test-retest repeatability of organ uptake on PSMA-targeted 18 F-DCFPyL PET/CT in patients with prostate cancer.

Test-retest repeatability of organ uptake on PSMA-targeted 18 F-DCFPyL PET/CT in patients with prostate cancer.

Journal: The Prostate

Published: November 16, 2022

Lack of repeatability of radiomic features derived from PET scans: Results from a 18 F-DCFPyL test-retest cohort.

Lack of repeatability of radiomic features derived from PET scans: Results from a 18 F-DCFPyL test-retest cohort.

Journal: The Prostate

Published: September 12, 2022

Interobserver Agreement Rates on Fibroblast Activation Protein Inhibitor-Directed Molecular Imaging and Therapy.

Interobserver Agreement Rates on Fibroblast Activation Protein Inhibitor-Directed Molecular Imaging and Therapy.

Journal: Clinical nuclear medicine

Published: April 19, 2022

A Novel Radiomics-Based Tumor Volume Segmentation Algorithm for Lung Tumors in FDG-PET/CT after 3D Motion Correction-A Technical Feasibility and Stability Study.

A Novel Radiomics-Based Tumor Volume Segmentation Algorithm for Lung Tumors in FDG-PET/CT after 3D Motion Correction-A Technical Feasibility and Stability Study.

Journal: Diagnostics (Basel, Switzerland)

Published: January 24, 2022

High SUVs Have More Robust Repeatability in Patients with Metastatic Prostate Cancer: Results from a Prospective Test-Retest Cohort Imaged with 18F-DCFPyL.

High SUVs Have More Robust Repeatability in Patients with Metastatic Prostate Cancer: Results from a Prospective Test-Retest Cohort Imaged with 18F-DCFPyL.

Journal: Molecular imaging

Published: November 19, 2021

Tumor heterogeneity for differentiation between liver tumors and normal liver tissue in 18F-FDG PET/CT.

Tumor heterogeneity for differentiation between liver tumors and normal liver tissue in 18F-FDG PET/CT.

Journal: Nuklearmedizin. Nuclear medicine

Published: November 03, 2020

High Interobserver Agreement for the Standardized Reporting System SSTR-RADS 1.0 on Somatostatin Receptor PET/CT.

High Interobserver Agreement for the Standardized Reporting System SSTR-RADS 1.0 on Somatostatin Receptor PET/CT.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: March 18, 2020

Semiquantitative Parameters in PSMA-Targeted PET Imaging with [18F]DCFPyL: Impact of Tumor Burden on Normal Organ Uptake.

Semiquantitative Parameters in PSMA-Targeted PET Imaging with [18F]DCFPyL: Impact of Tumor Burden on Normal Organ Uptake.

Journal: Molecular imaging and biology

Published: May 30, 2019

Showing 1-12 of 16

Last Updated: 09/26/2026